NEW YORK--(BUSINESS WIRE)--Sep. 23, 2009--
MSGI Security Solutions Inc. (OTCBB: MSGI) today reported that the
Company is launching its first product derived from NASA technology, a
handheld test for Diabetes, which uses breath instead of blood.
Nanobeak Inc., an MSGI subsidiary, is a nanotechnology company focused
on carbon based chemical sensing for gas and organic vapor detection.
Nanobeak will take the prototype handheld sensor, which measures acetone
levels with a simple breath, out of the laboratory and into the
marketplace. The first step involves product testing which will be done
in conjunction with a major hospital network in the United States,
followed by licensing discussions with the top pharmaceutical companies.
According to the International Diabetes Federation, Diabetes currently
affects 246 million people worldwide and is expected to affect 380
million by 2025. At least 50% of all people with Diabetes are unaware of
their condition. In some countries this figure may reach 80%. Every 10
seconds a person dies from Diabetes-related causes. India has the
largest number of people with Diabetes estimated at 40.9 million.
According to the American Diabetes Association, there are 23.6 million
children and adults in the United States with Diabetes.
Diabetes is a disease in which the body does not produce or properly use
insulin. Insulin is a hormone that is needed to convert sugar, starches
and other food into energy needed for daily life. The cause of Diabetes
continues to be a mystery, although both genetics and environmental
factors such as obesity and lack of exercise appear to play roles.
Acetone is the organic
compound with the formula
OC(CH3)2. This colorless liquid is the simplest
example of the ketones.
Ketones are the byproduct of a process called Gluconeogenesis
Jeremy Barbera, Chairman and CEO of MSGI commented; “we are excited to
announce the first breakthrough in technology that has reached the
prototype stage resulting from our new relationship with NASA. With
nearly 250 million people in the world affected by Diabetes, we see a
clear opportunity to partner with a major pharmaceutical company in
licensing our first product. This device will ultimately be marketed to
consumers who will be able to determine their health risks with nothing
more than a simple breath. If more than 50% of all people who have
Diabetes are unaware of that fact, our product will provide a seamless
test to save lives by providing early detection.
Nanobeak is the first of several majority owned subsidiaries, each of
which will hold the rights to a specific technology. We will be
announcing the other subsidiaries and their various breakthrough
technologies over the course of the next several weeks.”
About MSGI Security Solutions
MSGI Security Solutions, Inc. is a leading international provider of
proprietary solutions to commercial and government organizations. MSGI
is developing a combination of innovative emerging businesses that
leverage information and technology. The Company is headquartered in New
York City where it serves the needs of counter-terrorism, public safety,
and law enforcement. More information on MSGI is available on the
company's website at www.msgisecurity.com.
MSGI is a significant stakeholder in Current Technology Corporation.
The information contained in this news release, other than historical
information, consists of forward-looking statements within the meaning
of Section 27A of the Securities Act and Section 21E of the Exchange
Act. These statements may involve risks and uncertainties that could
cause actual results to differ materially from those described in such
statements. Although the Company believes that the expectations
reflected in such forward-looking statements are reasonable, it can give
no assurance that such expectations will prove to have been correct.
Important factors, including general economic conditions, spending
levels and other factors could cause actual results to differ materially
from the Company's expectations.
Source: MSGI Security Solutions Inc.
Jeremy Barbera, 516-524-2190